ADVFN US – Market Content Editor
-
Ascent Solar Shares Skyrocket on NASA Partnership for Beamed Power Innovation
Ascent Solar Technologies Inc. (NASDAQ:ASTI) saw its stock soar 160% after revealing a new collaboration with NASA aimed at advancing space-based beamed power technology using the company’s cutting-edge CIGS thin-film solar modules. Under a newly signed 12-month Collaborative Agreement Notice (CAN), Ascent will partner with NASA’s Marshall Space Flight Center and Glenn Research Center to…
-
Serve Robotics Shares Climb on Atlanta Launch, Expanding Autonomous Delivery Footprint
Shares of Serve Robotics Inc. (NASDAQ:SERV) rose 4.8% after the company announced its expansion into the Atlanta metropolitan area, marking a significant step in its nationwide growth strategy for autonomous sidewalk delivery. The move brings Serve’s delivery robots to neighborhoods such as Midtown, Old Fourth Ward, and Downtown Atlanta, offering service to more than 50,000…
-
Edgewise Therapeutics Shares Drop After FDA Withholds Accelerated Approval for Muscle Disorder Drug
Edgewise Therapeutics Inc. (NASDAQ:EWTX) saw its shares slide by 7.2% after the U.S. Food and Drug Administration (FDA) concluded that current data from the company’s CANYON trial does not meet the threshold for accelerated approval of sevasemten, its experimental treatment for Becker muscular dystrophy. Despite encouraging signs from the MESA open-label extension trial, which showed…
-
Vor Biopharma Shares Skyrocket on Global Licensing Deal for Autoimmune Therapy
Vor Biopharma Inc. (NASDAQ:VOR) saw its stock surge by 85% after unveiling a major licensing agreement with RemeGen Co., Ltd., a biotech firm based in China. The partnership grants Vor exclusive global rights—excluding China, Hong Kong, Macau, and Taiwan—to develop and commercialize telitacicept, an innovative fusion protein targeting autoimmune disorders. As part of the deal,…
-
Capital One Hits Record High of $210.70 Amid Discover Acquisition and Analyst Optimism
Capital One Financial Corporation (NYSE:COF) has reached a new milestone, with its stock hitting an all-time high of $210.70. This surge marks a standout moment for the company, capping off a 54.22% gain over the past year and pushing its market value to $80.55 billion. Analysts remain optimistic, highlighting the company’s solid fundamentals and strategic…
-
Charles Schwab Shares Climb to 52-Week High Amid Strong Momentum and Asset Growth
Charles Schwab (NYSE:SCHW) shares surged to a new 52-week peak, closing at $90.61, as the financial services giant continues to gain traction in 2025. The stock has delivered an impressive 22.13% return so far this year, reflecting steady investor optimism and confidence in the company’s long-term strategy. With a market capitalization of $164.2 billion and…
-
Benchmark Ups Tesla Price Target to $475 Following Robotaxi Debut in Austin
Benchmark has raised its price target for Tesla (NASDAQ:TSLA) to $475, up from a previous estimate of $350, citing the promising rollout of the company’s robotaxi pilot in Austin, Texas. According to analyst Mickey Legg, the pilot’s limited scope reflects a “measured and safety-driven strategy” that could enhance public and regulatory confidence in Tesla’s autonomous…
-
Dow Jones, S&P, Nasdaq, Futures Point To Positive Wall Street Open
U.S. equity futures signaled a positive open on Thursday, buoyed by a series of stronger-than-expected economic reports that lifted sentiment despite recent volatility and mixed prior session results. Weekly jobless claims data surprised to the downside, with the Labor Department reporting a decline to 236,000 for the week ending June 21. This was 10,000 fewer…
-
First-Time U.S. Unemployment Benefit Claims Down Unexpectedly
A report released by the Labor Department on Thursday showed first-time claims for U.S. unemployment benefits unexpectedly fell in the week ended June 21st. The Labor Department said initial jobless claims dipped to 236,000, a decrease of 10,000 from the previous week’s revised level of 246,000. Economists had expected jobless claims to come in unchanged…
-
Kewaunee Scientific Shares Jump 23.5% Following Strong Q4 Earnings Report
Kewaunee Scientific Corporation (NASDAQ:KEQU) delivered a robust finish to its fiscal year, posting fourth-quarter results that far outpaced the prior year and sparked a 23.5% surge in after-hours trading. For the quarter ending April 30, 2025, the laboratory equipment and furniture manufacturer reported adjusted earnings per share of $1.95, while revenue climbed 36.1% year-over-year to…